TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33428746

Group type: EXPERIMENTAL
Intervention: CrashCourse (CC)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Centers for Disease Control and Prevention (CDC) video education materials (CDC‐Vi)
Number of subjects: 118

Group type: COMPARATOR
Intervention: CDC written education materials (CDC‐Wr)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All education formats
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 118
Study: 36470113

Group type: EXPERIMENTAL
Intervention: Water sweetened with saccharine, sucralose, or aspartame + acesulfame-K (Asp+Ace-K)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Plain water (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Water sweetened with LNCS
Number of subjects: 42
Study: 35212274

Group type: EXPERIMENTAL
Intervention: GSMs-TACE plus synchronous antigen-presenting dendritic cell (DC) sequential reinfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSMs-TACE (control group)
Number of subjects: 0
Study: 32043439

Group type: EXPERIMENTAL
Intervention: Formal education
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Previous exposure to health education
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Interest in vector control tools
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Knowledge scores
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Protective measures usage
Number of subjects: 403
Study: 36151584

Group type: EXPERIMENTAL
Intervention: Perinatal Emotional Skills Groups (ESGs) + Treatment as Usual (TAU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study: 34962562

Group type: EXPERIMENTAL
Intervention: Inquiry-Based Stress Reduction (IBSR) program for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study: 34802026

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (tTXA) 1g (20mL) soaked in absorbable gelatin sponge
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (normal saline 20mL)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (tTXA)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 65
Study: 33191360

Group type: EXPERIMENTAL
Intervention: J-Valve
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Venus‐A
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: SAPIEN
Number of subjects: 163

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 163
Study: 35948761

Group type: EXPERIMENTAL
Intervention: SnF2 without‐iontophoresis
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: SnF2 with‐iontophoresis
Number of subjects: 26

Group type: COMPARATOR
Intervention: No SnF2 treatment
Number of subjects: 26
Study: 35403584

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand-rub disinfection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prior cleaning of stethoscopes
Number of subjects: 0
Study: 33144087

Group type: EXPERIMENTAL
Intervention: Positive test for Helicobacter pylori (Hp) infection
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Hp screening as part of clinical routine during AMI hospitalization
Number of subjects: 310
Study: 34267064

Group type: EXPERIMENTAL
Intervention: Radial Extracorporeal Shockwave Therapy (rESWT)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Autologous Blood Injection (ABI)
Number of subjects: 102
Study: 33932485

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 552

Group type: COMPARATOR
Intervention: Delayed coronary angiography
Number of subjects: 552
Study: 32597889

Group type: EXPERIMENTAL
Intervention: Detravenol
Number of subjects: 106

Group type: COMPARATOR
Intervention: Detralex®
Number of subjects: 106
Study: 35275078

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 204
Study: 36775506

Group type: EXPERIMENTAL
Intervention: Myofascial Release (MFR) techniques
Number of subjects: 42
Study: 33410387

Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT), 5-week adaptive program, n = 37
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waiting list control group, n = 38
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT)
Number of subjects: 75
Study: 32342889

Group type: EXPERIMENTAL
Intervention: Warp knitted spacer fabrics on car seat shell
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard seat
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anthropodynamic dummy test
Number of subjects: 16
Study: 35363455

Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation (IVES) two times a week for 10 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation (IVES) five times a week for 4 weeks
Number of subjects: 52
Study: 33507949

Group type: EXPERIMENTAL
Intervention: NAT-C guided consultation (Arm I)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care (Arm II)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: NAT-C intervention
Number of subjects: 47
Study: 34950442

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia
Number of subjects: 115

Group type: COMPARATOR
Intervention: General anesthesia with tracheal intubation
Number of subjects: 115
Study: 32215767

Group type: EXPERIMENTAL
Intervention: Debridement and laser treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Debridement alone (Control)
Number of subjects: 27
Study: 36239523

Group type: EXPERIMENTAL
Intervention: New birthing room designed with more person‐centered considerations (n = 204)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Regular birthing room (n = 202)
Number of subjects: 406
Study: 33753147

Group type: EXPERIMENTAL
Intervention: Baicalein tablets (200 mg, 400 mg, 600 mg, or 800 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baicalein tablets (200 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baicalein tablets (400 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baicalein tablets (600 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baicalein tablets (800 mg)
Number of subjects: 80
Study: 32199520

Group type: EXPERIMENTAL
Intervention: Personal health monitoring (PHM) device for 12 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Personal health monitoring (PHM) device
Number of subjects: 24
Study: 36104159

Group type: EXPERIMENTAL
Intervention: Simple notes with continuous access
Number of subjects: 53

Group type: COMPARATOR
Intervention: Complex notes with continuous access
Number of subjects: 53

Group type: COMPARATOR
Intervention: Simple notes with initial access
Number of subjects: 53

Group type: COMPARATOR
Intervention: Complex notes with initial access
Number of subjects: 53
Study: 34174392

Group type: EXPERIMENTAL
Intervention: Aerobic walking intervention
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Social dance intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 180
Study: 34794898

Group type: EXPERIMENTAL
Intervention: Modified Menghini-type needle (20-gauge antegrade bevel)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Original 22-gauge reverse bevel needle
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 52
Study: 33789011

Group type: EXPERIMENTAL
Intervention: 15 mg upadacitinib
Number of subjects: 1704

Group type: EXPERIMENTAL
Intervention: 30 mg upadacitinib
Number of subjects: 1704

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1704

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 1704

Group type: EXPERIMENTAL
Intervention: 15 mg upadacitinib vs. Adalimumab
Number of subjects: 1704

Group type: EXPERIMENTAL
Intervention: 30 mg upadacitinib vs. Adalimumab
Number of subjects: 1704

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1704
Study: 36131324

Group type: EXPERIMENTAL
Intervention: L-carnitine 1000 mg/day
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 32680441

Group type: EXPERIMENTAL
Intervention: SidekickHealth smartphone application
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 37
Study: 33742204

Group type: EXPERIMENTAL
Intervention: Cartoon watching
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Distraction card
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study: 32526448

Group type: EXPERIMENTAL
Intervention: Basophil count in overweight individuals
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Basophil count in moderately obese individuals
Number of subjects: 119

Group type: COMPARATOR
Intervention: Blood markers (MADRS, CGI, ODQ)
Number of subjects: 119
Study: 35715786

Group type: EXPERIMENTAL
Intervention: 24 text messages during eight weeks (three text messages per week)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 82
Study: 33012059

Group type: EXPERIMENTAL
Intervention: D‐B Nestnet model
Number of subjects: 94

Group type: COMPARATOR
Intervention: Original Unet model
Number of subjects: 94
Study: 36036067

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation for 8 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine outpatient treatment
Number of subjects: 45
Study: 33509164

Group type: EXPERIMENTAL
Intervention: Transcutaneous perineal electrostimulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intracavitary anal electrostimulation
Number of subjects: 70
Study: 33238931

Group type: EXPERIMENTAL
Intervention: WiseApp intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (walk step reminders, videos, and surveys focused on overall wellness)
Number of subjects: 200
Study: 34473750

Group type: EXPERIMENTAL
Intervention: Peer counselling
Number of subjects: 588

Group type: COMPARATOR
Intervention: Routine counselling (standard of care)
Number of subjects: 588
Study: 32182586

Group type: EXPERIMENTAL
Intervention: Standard warm-up (10 min at 60% of VO2peak)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PAP warm-up (5 min at 60% of VO2peak followed by three 10-s all-out sprints)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No warm-up
Number of subjects: 15
Study: 33074892

Group type: EXPERIMENTAL
Intervention: WHO Surgical Safety Checklist
Number of subjects: 3702
Study: 32847946

Group type: EXPERIMENTAL
Intervention: Nocturnal low-dose dexmedetomidine (DEX); n=50
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PLA); n=50
Number of subjects: 100
Study: 35776029

Group type: EXPERIMENTAL
Intervention: Atropine-neostigmine (20 mcg/kg - 50 mcg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg)
Number of subjects: 60
Study: 33388382

Group type: EXPERIMENTAL
Intervention: Netupitant/palonosetron (NEPA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 35218286

Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP)
Number of subjects: 20
Study: 32580620

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (1200 mg) + weight loss regime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faradic (three 1 hour sessions) + weight loss regime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (1200 mg) + Faradic (three 1 hour sessions) + weight loss regime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (1200 mg) + weight loss regime
Number of subjects: 0
Study: 33297766

Group type: EXPERIMENTAL
Intervention: Posterior knot position
Number of subjects: 216

Group type: COMPARATOR
Intervention: Anterior knot position
Number of subjects: 216
Study: 33631337

Group type: EXPERIMENTAL
Intervention: Preoperative calcium and calcitriol supplementation (calcitriol 0.25 μg po bid and calcium carbonate 1,500 mg po tid 5 days preoperatively and continued postoperatively)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Postoperative calcium and calcitriol supplementation (started postoperatively)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Preoperative calcium and calcitriol supplementation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Postoperative calcium and calcitriol supplementation
Number of subjects: 82
Study: 34002565

Group type: EXPERIMENTAL
Intervention: Herb-separated moxibustion on segmental conception vessel combined with low-frequency TEAS (2 Hz, 10-15 mA, once every 2 days for 30 min, moxibustion once every 10 days for 3 months)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-frequency TEAS (2 Hz, 10-15 mA, once every 2 days for 30 min)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Medication group (vitamin E capsules, coenzyme Q10 capsules, Wuzi Yanzong pills)
Number of subjects: 105
Study: 35288439

Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 144
Study: 34706555

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (4 g daily)
Number of subjects: 8179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study: 32692994

Group type: EXPERIMENTAL
Intervention: Whole blood arsenic level (measured in μg/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood arsenic levels above 3.69 μg/L (Log As ≥0.57)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood arsenic levels in smokers (≥15 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood arsenic levels less than 3.69 μg/L
Number of subjects: 0
Study: 35758289

Group type: EXPERIMENTAL
Intervention: Terbuthylazine + glyphosate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atrazine + glyphosate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: [Atrazine + mesotrione] + glyphosate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isolated glyphosate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nontreated control
Number of subjects: 10
Study: 33535835

Group type: EXPERIMENTAL
Intervention: Fluzoparib (120 mg) under fed conditions
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fluzoparib (120 mg) under fasted conditions
Number of subjects: 16
Study: 35093205

Group type: EXPERIMENTAL
Intervention: hIVIG
Number of subjects: 593
Study: 33166271

Group type: EXPERIMENTAL
Intervention: Registry-based clinical trials for ACC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized registry-based trials in an adjuvant setting and for advanced disease
Number of subjects: 0
Study: 35488667

Group type: EXPERIMENTAL
Intervention: IONM group
Number of subjects: 120

Group type: COMPARATOR
Intervention: non-IONM group
Number of subjects: 120
Study: 34089936

Group type: EXPERIMENTAL
Intervention: 12-hour fasting treatment in 35 six-month-old laying pigeons, divided into 7 groups by different DELCs.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Not applicable (control group not specified).
Number of subjects: 70
Study: 33515281

Group type: COMPARATOR
Intervention: Plasma oxalate (Pox) levels
Number of subjects: 106
Study: 32410362

Group type: EXPERIMENTAL
Intervention: Oral methotrexate (MTX)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: OMP dexamethasone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination of oral MTX and OMP dexamethasone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 33904625

Group type: EXPERIMENTAL
Intervention: 0.75 g CG per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.5 g CG per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3 g CG per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6 g CG per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dietary CG
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no CG)
Number of subjects: 40
Study: 32289723

Group type: EXPERIMENTAL
Intervention: rotational field TMS (rfTMS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: conventional unidirectional TMS (udTMS)
Number of subjects: 8
Study: 34625316

Group type: EXPERIMENTAL
Intervention: Group A (received the core and up to 4 custom elements of treatment, wrote what each image displayed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (presentation of the 18 elements with core elements chunked at the end followed by up to 4 custom elements)
Number of subjects: 0
Study: 33635325

Group type: EXPERIMENTAL
Intervention: Collaborative care (cognitive behavioral therapy and care management delivered mostly through telehealth for 6 months)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 32969686

Group type: EXPERIMENTAL
Intervention: Monitor and Accept (MA) training, an 8-week mindfulness-based stress reduction (MBSR) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitor Only (MO) training, a modified 8-week MBSR-adapted intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Treatment (NT) control
Number of subjects: 0
Study: 36052772

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus pemetrexed and carboplatin or cisplatin (APP)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Pemetrexed plus carboplatin or cisplatin (PP)
Number of subjects: 163
Study: 34063790

Group type: EXPERIMENTAL
Intervention: Vitamin A deficiency (VAD) prevalence in Non-Hispanic Black and Hispanic pregnant women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allele frequencies of vitamin A-related SNPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minor allele frequencies of SNPs associated with vitamin A metabolism
Number of subjects: 0
Study: 32305099

Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin-bevacizumab (experimental group)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Carboplatin-gemcitabine-bevacizumab (standard group)
Number of subjects: 682
Study: 35568683

Group type: EXPERIMENTAL
Intervention: LDL-C 190-219 mg/dL
Number of subjects: 5786

Group type: EXPERIMENTAL
Intervention: LDL-C 220-249 mg/dL
Number of subjects: 5786

Group type: EXPERIMENTAL
Intervention: LDL-C 250-299 mg/dL
Number of subjects: 5786

Group type: EXPERIMENTAL
Intervention: LDL-C ≥300 mg/dL
Number of subjects: 5786
Study: 36264432

Group type: EXPERIMENTAL
Intervention: Patient navigator program (immediate intervention group)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 162
Study: 33900801

Group type: EXPERIMENTAL
Intervention: Hopefulness
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Work stress
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 226
Study: 32448790

Group type: EXPERIMENTAL
Intervention: 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 270

Group type: COMPARATOR
Intervention: PHiD-CV10 and PCV13
Number of subjects: 270
Study: 32205331

Group type: EXPERIMENTAL
Intervention: Pre-tied non-adhesive tape (PT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Thomas Tube Holder (TH)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Gauze roll (GR)
Number of subjects: 300
Study: 32921665

Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Febuxostat
Number of subjects: 24
Study: 35215537

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet (GI < 35, n = 17)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) diet (GI > 70, n = 18)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control diet (GI = 55–58)
Number of subjects: 35
Study: 34510154

Group type: EXPERIMENTAL
Intervention: Eyesi Indirect Ophthalmoscope simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peer practice
Number of subjects: 0
Study: 35488859

Group type: EXPERIMENTAL
Intervention: Bolus administration of FDG
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Constant infusion of FDG
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hybrid bolus/infusion of FDG
Number of subjects: 15
Study: 32277105

Group type: EXPERIMENTAL
Intervention: PCV13 vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Having siblings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carrying any pneumococcal serotype
Number of subjects: 0
Study: 34176407

Group type: EXPERIMENTAL
Intervention: Baricitinib therapy
Number of subjects: 0
Study: 32058845

Group type: EXPERIMENTAL
Intervention: HA-WBRT plus memantine
Number of subjects: 518

Group type: COMPARATOR
Intervention: WBRT plus memantine
Number of subjects: 518
Study: 35917647

Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed-platinum
Number of subjects: 397

Group type: COMPARATOR
Intervention: placebo + pemetrexed-platinum
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed-platinum (after adjusting for crossover)
Number of subjects: 397
Study: 32194252

Group type: EXPERIMENTAL
Intervention: In-home, nurse practitioner-led care management team
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephonic care management program
Number of subjects: 0
Study: 36610544

Group type: EXPERIMENTAL
Intervention: Deg-100
Number of subjects: 260

Group type: COMPARATOR
Intervention: Gla-300
Number of subjects: 260
Study: 34197452

Group type: EXPERIMENTAL
Intervention: Pharmaceutical and healthy lifestyle interventions
Number of subjects: 31326

Group type: COMPARATOR
Intervention: Usual hypertension and diabetes care (Control)
Number of subjects: 31326
Study: 33136059

Group type: EXPERIMENTAL
Intervention: Intervention for patients (educational group program, monitoring via logs, web-based platform, automated SMS)
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Combined intervention (for both patients and professionals)
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Intervention for professionals (educational program, decision support tool, periodic feedback)
Number of subjects: 2334

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2334
Study: 33749970

Group type: EXPERIMENTAL
Intervention: Lean Body Mass (LBM) dosing
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ideal Body Weight (IBW) dosing
Number of subjects: 19

Group type: COMPARATOR
Intervention: Total Body Weight (TBW) dosing
Number of subjects: 19